Results 11 to 20 of about 303,727 (299)

Intermediate Density Lipoprotein Cholesterol Measurement [PDF]

open access: hybridDefinitions, 2020
The determination of the amount of intermediate density lipoprotein present in a sample.
National Cancer Institute
semanticscholar   +3 more sources

Non-high-density lipoprotein (non-HDL) cholesterol in adolescence as a predictor of atherosclerotic cardiovascular diseases in adulthood [PDF]

open access: yesReviews in Cardiovascular Medicine, 2021
Defined as the total cholesterol minus high-density lipoprotein (HDL), non-HDL cholesterol has been increasingly acknowledged as a measure of risk estimation for developing atherosclerotic cardiovascular diseases (ASCVD).
Saeed Shoar   +7 more
doaj   +2 more sources

Effects of lipid-lowering drugs on intermediate-density lipoprotein in uremic patients [PDF]

open access: yesKidney International, 1999
Patients with chronic renal failure often have alterations in lipoprotein profile including elevated very-low density lipoprotein (VLDL) and intermediate density lipoprotein (IDL), and reduced high density lipoprotein (HDL) levels. Among these changes, raised IDL has been shown as an independent risk factor for atherosclerosis in hemodialysis patients.
Nishizawa, Yoshiki   +4 more
openaire   +3 more sources

Intermediate-density lipoprotein and cholesterol-rich very low density lipoprotein in angiographically determined coronary artery disease. [PDF]

open access: yesCirculation, 1981
The relationship between the concentrations of intermediate-density lipoprotein (IDL) and other lipoproteins and the extent of coronary artery disease (CAD) was studied in 182 consecutive patients evaluated by selective coronary cineangiography. On univariate analysis, the extent of CAD correlated significantly and positively with very low density ...
R, Tatami   +14 more
openaire   +3 more sources

Evidence for changing lipid management strategy to focus on non-high density lipoprotein cholesterol

open access: yesLipids in Health and Disease, 2019
Low-density lipoprotein cholesterol (LDL-C) has been recommended as the primary treatment target on lipid management in coronary heart disease (CHD) patients for past several decades.
Xin Su, Yi Kong, Daoquan Peng
doaj   +2 more sources

Delayed In Vivo Catabolism of Intermediate-Density Lipoprotein and Low-Density Lipoprotein in Hemodialysis Patients as Potential Cause of Premature Atherosclerosis [PDF]

open access: bronzeArteriosclerosis, Thrombosis and Vascular Biology, 2005
Katsunori Ikewaki   +11 more
openalex   +2 more sources

Lipoprotein profile in men with peripheral vascular disease. Role of intermediate density lipoproteins and apoprotein E phenotypes. [PDF]

open access: yesCirculation, 1992
BACKGROUND The role of lipoprotein disturbances in the development of peripheral vascular disease (PVD) has not been sufficiently clarified. METHODS AND RESULTS The relations among concentrations of intermediate density lipoproteins (IDL), apoprotein (apo) B, apo E, and other ...
M, Sentí   +4 more
openaire   +3 more sources

Studies on abnormalities in serum intermediate density lipoproteins during maintenance hemodialysis

open access: bronzeJournal of Japanese Society for Dialysis Therapy, 1987
園部 美弥彦   +8 more
openalex   +3 more sources

Mechanism, clinical consequences, and management of dyslipidemia in children with nephrotic syndrome [PDF]

open access: yesChildhood Kidney Diseases, 2022
Dyslipidemia in nephrotic syndrome (NS) is often characterized by marked increases in the levels of total cholesterol, triglycerides, low-density lipoprotein cholesterol, and other lipoproteins, such as very low-density lipoprotein, intermediate-density ...
Hee Sun Baek
doaj   +1 more source

Home - About - Disclaimer - Privacy